Depression Clinical Trial
Official title:
Telephone Versus Face-to-Face Administration of CBT for Depression
This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.
Major depressive disorder is a common and often long-lasting disorder with 12-month
prevalence rates estimated to be between 6.6% and 10.3%. Although the personal and societal
costs of depression are high, it is well established that depression can be effectively
treated using antidepressant medication and/or forms of psychotherapy. Several studies have
found that when given a choice, about two-thirds of depressed patients prefer psychotherapy
or counseling over antidepressant medication. However, a variety of barriers exist to
initiating and maintaining psychotherapy. Only about 20% of all patients referred for
psychotherapy actually initiate treatment, and of those who do initiate treatment, nearly
half drop out before completing treatment. The use of the telephone to deliver treatment
services has been recommended as a way to reduce many of the barriers associated with
failure to initiate and sustain treatment. When administered over the telephone, cognitive
behavioral therapy (CBT), a form of psychotherapy that teaches ways to modify thoughts and
behaviors that contribute to depression, may be superior to face-to-face CBT in improving
treatment adherence and reducing depressive symptoms. This study will compare the
effectiveness of telephone CBT (T-CBT) versus face-to-face CBT (FtF-CBT) in treating people
with depression.
Participation in this study will include 18 weeks of treatment and 12 months of follow-up.
All participants will first undergo baseline assessments that will include a telephone
interview and questionnaires about mood. Participants will then be assigned randomly to
receive T-CBT or FtF-CBT. Participants in both groups will receive eighteen 45-minute
sessions of their assigned treatment over 18 weeks. Sessions will occur twice a week for 2
weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. During
sessions, participants will learn ways to modify thoughts and behaviors that contribute to
their depression and ways to maintain the lifestyle changes that they have made. Treatment
sessions will be identical for both groups, except one group will receive sessions over the
telephone and the other in-person at a study office. All participants will repeat the
baseline assessments at Weeks 4, 9, 14, and 18 of treatment and Months 3, 6, 9, and 12 of
follow-up.
;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
| Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
| Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
| Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
| Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
| Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
| Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
| Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
| Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
| Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
| Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
| Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
| Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
| Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
| Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |